This topic contains a solution. Click here to go to the answer

Author Question: The difference between moral hazard and adverse selection is a. moral hazard has to do with ... (Read 286 times)

justinmsk

  • Hero Member
  • *****
  • Posts: 524
The difference between moral hazard and adverse selection is
 a. moral hazard has to do with unobservable characteristics of individuals
  b. moral hazard has to do with unobservable actions of individuals
  c. adverse selection is when individuals change their behaviors because of a contract
  d. adverse selection is when you choose the wrong answer on a test

Question 2

The invisible hand using Adam Smith's terminology refers to
 a. government control of the market.
  b. market forces working through the price mechanism.
  c. the money supply that serves to keep the economy working smoothly.
  d. the role of innovation in maintaining a steady rate of growth.
  e. behind-the-scenes policy making to influence how markets allocate scarce resources.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jliusyl

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

b

Answer to Question 2

B




justinmsk

  • Member
  • Posts: 524
Reply 2 on: Jul 1, 2018
Thanks for the timely response, appreciate it


Animal_Goddess

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library